# A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis

> **NCT00440518** · PHASE2 · COMPLETED · sponsor: **UCB Pharma** · enrollment: 218 (actual)

## Conditions studied

- Migraine

## Interventions

- **DRUG:** Lacosamide
- **OTHER:** Placebo
- **DRUG:** Lacosamide

## Key facts

- **NCT ID:** NCT00440518
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 218 (ACTUAL)
- **Last updated:** 2018-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00440518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00440518, "A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00440518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*